Literature DB >> 1681342

Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy.

M A Conway1, J Allis, R Ouwerkerk, T Niioka, B Rajagopalan, G K Radda.   

Abstract

Phosphorus-31 magnetic resonance spectroscopy can be used to study intracellular biochemistry non-invasively by measuring the relative proportions of high energy phosphates. Study of deteriorating cardiac metabolism might be useful in the management of hypertrophy and heart failure. 31P magnetic resonance spectroscopy was carried out in fourteen patients with aortic valve disease (six with aortic stenosis, eight with aortic incompetence). Six patients were receiving treatment for symptoms of heart failure. The phosphocreatine (PCr) to ATP ratio in these patients (1.1 [SD 0.32]) was significantly lower than that in thirteen controls (1.5 [0.2], p less than 0.001) or in the eight patients who did not have symptoms of heart failure (1.56 [0.15], p less than 0.0035). These findings indicate that heart failure in aortic valve disease is associated with low PCr, which could be due to loss of intracellular creatine. The measurement could eventually have a role in helping to determine the optimum timing for aortic valve replacement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681342     DOI: 10.1016/0140-6736(91)91838-l

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  85 in total

1.  Control of cardiac energetics: from models to human disease.

Authors:  J C Hopkins; K Clarke; G K Radda
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

2.  Functional and metabolic consequences of aortic valve replacement.

Authors:  H J Lamb
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

3.  Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium.

Authors:  S Neubauer; M Beer; W Landschütz; J Sandstede; T Seyfarth; C Lipke; H Köstler; W Pabst TKenn; M Meininger; M von Kienlin; M Horn; K Harre; D Hahn
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.310

4.  Impaired ATP kinetics in failing in vivo mouse heart.

Authors:  Ashish Gupta; Vadappuram P Chacko; Michael Schär; Ashwin Akki; Robert G Weiss
Journal:  Circ Cardiovasc Imaging       Date:  2010-10-06       Impact factor: 7.792

Review 5.  Magnetic resonance imaging in valvular heart disease.

Authors:  M Schmidt; J Crnac; B Dederichs; P Theissen; H Schicha; U Sechtem
Journal:  Int J Card Imaging       Date:  1997-06

Review 6.  Cardiac spectroscopy: techniques, indications and clinical results.

Authors:  Meinrad Beer
Journal:  Eur Radiol       Date:  2004-03-06       Impact factor: 5.315

7.  Magnetic resonance spectroscopy in congenital heart disease.

Authors:  V M Miall-Allen; G J Kemp; B Rajagopalan; D J Taylor; G K Radda; S G Haworth
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 8.  Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review.

Authors:  Yuchi Liu; Yuning Gu; Xin Yu
Journal:  Quant Imaging Med Surg       Date:  2017-12

9.  Creatine--a dispensable metabolite?

Authors:  Heinrich Taegtmeyer; Joanne S Ingwall
Journal:  Circ Res       Date:  2013-03-15       Impact factor: 17.367

10.  Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance.

Authors:  Ashish Gupta; V P Chacko; Robert G Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.